Istituto Auxologico Italiano
auxologico.itLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
202
Active
63
Phase 3
2
Total enrollment
54,996
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| rhGH | — | — | — | — | — | 1 | |
| Genotyping | — | — | — | — | — | 1 | |
| Collection of biological parameters | — | — | — | — | — | 1 | |
| NGS sequencing | — | — | — | — | — | 1 |
Next readouts
- 2025-10-31
- 2025-12-31
- 2027-05
- 2027-10-30
Top conditions
- Obesity33
- Anorexia Nervosa15
- Hypertension10
- Parkinson Disease8
- Amyotrophic Lateral Sclerosis7
- Stroke7
- Multiple Sclerosis6
- Osteoporosis6
Frequently asked questions about Istituto Auxologico Italiano
- How many clinical trials does Istituto Auxologico Italiano have on ClinicalTrials.gov?
- Istituto Auxologico Italiano is listed as the lead sponsor on 202 clinical trials in ClinicalTrials.gov, 63 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Istituto Auxologico Italiano's trials are in Phase 3?
- 2 of Istituto Auxologico Italiano's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Istituto Auxologico Italiano focus on?
- Istituto Auxologico Italiano's most-studied conditions on ClinicalTrials.gov are Obesity, Anorexia Nervosa, Hypertension, Parkinson Disease, Amyotrophic Lateral Sclerosis.
- When are Istituto Auxologico Italiano's next clinical trial readouts?
- Istituto Auxologico Italiano has 4 upcoming primary-completion readouts tracked here; the soonest is “Understanding, Diagnosis and Monitoring of Thyroid Hormone Action Defects”, expected around 2025-10-31.